Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
43
datasets available to search
ShareScore release 0.9.0
Dataset results
43 results for “Allogenic T-cells”
Allogenic and Autologous anti-CD7 CAR-T cell Therapies in Relapsed or Refractory T-Cell Malignancies
GEO Series GSE227828. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
ClinicalTrials.gov study NCT05487651. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01758328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
ClinicalTrials.gov study NCT01535885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
ClinicalTrials.gov study NCT01941680. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
ClinicalTrials.gov study NCT00228631. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT03719105. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
ClinicalTrials.gov study NCT04881240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia
ClinicalTrials.gov study NCT00017654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
ClinicalTrials.gov study NCT06925685. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express t
ClinicalTrials.gov study NCT01082926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
ClinicalTrials.gov study NCT00814983. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
ClinicalTrials.gov study NCT06514794. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
ClinicalTrials.gov study NCT05822427. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
ClinicalTrials.gov study NCT04248192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06671717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
ClinicalTrials.gov study NCT07085104. IPD Sharing: NO. Countries: 2. Publications: 0.
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
ClinicalTrials.gov study NCT05377827. IPD Sharing: NO. Countries: 1. Publications: 0.
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01746849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion
ClinicalTrials.gov study NCT06180499. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.